Skip to content
20-F

Annual Report (Foreign)

Scinai Immunotherapeutics Ltd. SCNI

0001213900-26-038011

← back to feed
Filed
Apr 1, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 9.34B sh
Shares Diluted FY 2025 · Dec 31, 2024 3.23B sh
Shares Diluted FY 2025 · Dec 31, 2023 1.56B sh
Shares Outstanding FY 2025 · Dec 31, 2025 13.87B sh
Capex FY 2025 · Dec 31, 2025 $24K
Capex FY 2025 · Dec 31, 2024 $12K
Capex FY 2025 · Dec 31, 2023 $637K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$6.03M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$6.34M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$9.38M
Cash And Equivalents FY 2025 · Dec 31, 2025 $1.66M
Cash And Equivalents FY 2025 · Dec 31, 2024 $1.96M
Cash And Equivalents FY 2025 · Dec 31, 2023 $4.87M
Stockholders Equity FY 2025 · Dec 31, 2025 $8.1M
Stockholders Equity FY 2025 · Dec 31, 2024 $9.98M
Stockholders Equity FY 2025 · Dec 31, 2023 −$4.57M
Stockholders Equity FY 2025 · Dec 31, 2022 −$1.76M
Current Liabilities FY 2025 · Dec 31, 2025 $1.59M
Current Liabilities FY 2025 · Dec 31, 2024 $1.81M
Current Assets FY 2025 · Dec 31, 2025 $2.05M
Current Assets FY 2025 · Dec 31, 2024 $2.39M
Total Assets FY 2025 · Dec 31, 2025 $11.63M
Total Assets FY 2025 · Dec 31, 2024 $13.45M
Sga Expense FY 2025 · Dec 31, 2025 $2.52M
Sga Expense FY 2025 · Dec 31, 2024 $2.53M
Sga Expense FY 2025 · Dec 31, 2023 $4.51M
Rd Expense FY 2025 · Dec 31, 2025 $2.37M
Rd Expense FY 2025 · Dec 31, 2024 $5.53M
Rd Expense FY 2025 · Dec 31, 2023 $5.21M
Net Income FY 2025 · Dec 31, 2025 −$8.31M
Net Income FY 2025 · Dec 31, 2024 $4.8M
Net Income FY 2025 · Dec 31, 2023 −$6.5M
Operating Income FY 2025 · Dec 31, 2025 −$7.54M
Operating Income FY 2025 · Dec 31, 2024 −$8.64M
Operating Income restated FY 2025 · Dec 31, 2023 −$9.71M
Gross Profit FY 2025 · Dec 31, 2025 −$2.65M
Gross Profit FY 2025 · Dec 31, 2024 −$580K
Cost Of Revenue FY 2025 · Dec 31, 2025 $3.96M
Cost Of Revenue FY 2025 · Dec 31, 2024 $1.24M
Revenue FY 2025 · Dec 31, 2025 $1.31M
Revenue FY 2025 · Dec 31, 2024 $658K
Eps Diluted restated FY 2025 · Dec 31, 2023 $0.00
Eps Basic restated FY 2025 · Dec 31, 2023 $0.00